PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?

Ramón Cantero-CidJosé Casas-MartinEnrique Hernández-JiménezCarolina Cubillos-ZapataAníbal Varela-SerranoJosé Avendaño-OrtizMarta CasarrubiosKarla Montalbán-HernándezIgnacio Villacañas-GilLaura Guerra-PastriánBegoña PeinadoCristóbal MarcanoLuis Augusto AguirreEduardo López-Collazo

Published in: BMC cancer (2018)

These results emphasise the interesting nature of immune checkpoint shifting therapies, which have potential clinical applications in the context of colorectal cancer.

Keyphrases

induced apoptosis
cell cycle arrest
endoplasmic reticulum stress
cell death
risk assessment
drug delivery
cell proliferation
climate change